GXI:XETRA Gerresheimer AG

EUR 106.10 0.90 0.855513
Icon

Gerresheimer AG (GXI:XETRA) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 106.10

+0.90 (+0.86)%

EUR 3.63B

0.07M

N/A

N/A

Icon

GXI:XETRA

Gerresheimer AG (EUR)
COMMON STOCK | XETRA
EUR 106.10
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 3.63B

N/A

EUR 106.10

Gerresheimer AG (GXI:XETRA) Stock Forecast

N/A

Based on the Gerresheimer AG stock forecast from 0 analysts, the average analyst target price for Gerresheimer AG is not available over the next 12 months. Gerresheimer AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Gerresheimer AG is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Gerresheimer AG’s stock price was EUR 106.10. Gerresheimer AG’s stock price has changed by +4.33% over the past week, +17.50% over the past month and +22.02% over the last year.

No recent analyst target price found for Gerresheimer AG
No recent average analyst rating found for Gerresheimer AG

Company Overview Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The compan...Read More

Klaus-Bungert-Strasse 4, Düsseldorf, Germany, 40468

11,660

November

EUR

Germany

Adjusted Closing Price for Gerresheimer AG (GXI:XETRA)

Loading...

Unadjusted Closing Price for Gerresheimer AG (GXI:XETRA)

Loading...

Share Trading Volume for Gerresheimer AG Shares

Loading...

Compare Performance of Gerresheimer AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GXI:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Gerresheimer AG (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CBHD:XETRA
Coloplast A/S -0.40 (-0.32%) EUR28.24B 41.84 3.91

ETFs Containing GXI

Symbol Name GXI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Gerresheimer AG (GXI:XETRA) Stock

Stock Target Advisor's fundamental analysis for Gerresheimer AG's stock is Neutral.

GXI:XETRA stock's dividend yield is 1.19%. Our analysis grades GXI:XETRA stock's dividend yield at D+. This means that GXI:XETRA stock's dividend yield is above 67% of the stocks in the Medical Instruments & Supplies sector in the XETRA exchange. Based on this GXI:XETRA may be a average dividend stock for its sector.

Unfortunately we do not have enough data on GXI:XETRA's stock to indicate what its average analyst target is.

GXI:XETRA stock's Price/Earning ratio is 30.23. Our analysis grades GXI:XETRA stock's Price / Earning ratio at B. This means that GXI:XETRA stock's Price/Earning ratio is above 14% of the stocks in the Medical Instruments & Supplies sector in the XETRA exchange. Based on this GXI:XETRA may be undervalued for its sector.

The last closing price of GXI:XETRA's stock was EUR 106.10.

The most recent market capitalization for GXI:XETRA is EUR 3.63B.

Unfortunately we do not have enough analyst data on GXI:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Gerresheimer AG's stock.

As per our most recent records Gerresheimer AG has 11,660 Employees.

Gerresheimer AG's registered address is Klaus-Bungert-Strasse 4, Düsseldorf, Germany, 40468. You can get more information about it from Gerresheimer AG's website at https://www.gerresheimer.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...